This position statement provides guidelines for assessing risk associated with carotid endarterectomy and defines the point at which risk is too high to perform surgery for specific indications described below. Morbidity and mortality levels are discussed. This statement does not address indications for surgery or merits of specific medical or surgical treatments. Results of current studies that compare relative risk of various treatments for carotid artery disease are not yet available. (Circulation 1989;79:472-473) C arotid endarterectomy for arteriosclerotic occlusive disease of the carotid artery bifurcation and the internal carotid artery has been widely used as a method of reducing stroke risk. There is a variable risk that surgery may induce the condition it is designed to prevent, stroke due to cerebral infarction. Incidence of this complication varies among surgeons and medical institutions.
C arotid endarterectomy for arteriosclerotic occlusive disease of the carotid artery bifurcation and the internal carotid artery has been widely used as a method of reducing stroke risk. There is a variable risk that surgery may induce the condition it is designed to prevent, stroke due to cerebral infarction. Incidence of this complication varies among surgeons and medical institutions.
The risk of carotid endarterectomy should properly influence the indication for surgery. If the risk of operating on a patient is low in relation to the risk of not operating, then the benefit of carotid endarterectomy as a least-risk strategy may be proportionately great and worthwhile. The converse is also true. If morbidity and mortality of carotid endarterectomy are excessive in proportion to the natural history of the untreated or nonoperatively treated lesion, surgery should be avoided.
The ad hoc committee recognizes there are insufficient data to define acceptable morbidity and mortality limits for carotid endarterectomy for various indications. Nevertheless, the committee believes the upper limits of morbidity and mortality that shouldprompt individualpeer review can be defined. A small minority of patients will have indications for surgery outside these categories and should be evaluated individually.
The lowest expected morbidity and mortality levels for each category are not known; a more direct comparison of surgical and nonsurgical treatment may be needed, requiring further revision of these limits. The scientific councils of the American Heart Association will continue to monitor these levels and make appropriate revisions as necessary. 
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